7 May 2024 – The parties are continuing their work to solve problems and to establish a schedule for specialized and general discovery. Apparently, both sides have agreed to hold the investigation to take place between 2024 and 2525. April 18, 2020– Plaintiffs selected their proposed cases and a Defendant’s motion extended. The parties work on the general investigation, and the judge has notified both parties of their closing date. The 2nd February 2019 Discovery will be opened and the parties agree to an agreement to process electronic data.
Tepezza Hearings
The recent hearings on Tepezza, a drug used to treat thyroid eye disease, have drawn significant attention. Patients from across the United States have raised concerns about severe hearing loss and tinnitus, allegedly linked to the medication. These testimonies highlight the potential risks involved with Tepezza, sparking a wave of legal actions and intense scrutiny from medical professionals and regulatory bodies.
Patients who have experienced these severe side effects are now seeking to file a Tepezza hearing loss lawsuit to hold the manufacturer accountable and seek compensation for their suffering. Many are looking to file a Tepezza lawsuit to address the hearing-related side effects they have endured.
At Mass Tort America, we understand the distress that these revelations can cause. Our team is dedicated to helping those affected by Tepezza navigate the legal complexities and seek compensation for their suffering. With our nationwide reach and dedicated Concierge Team, we aim to provide comprehensive support to patients in need.
What Is Tepezza Used For?
Horizon Therapeutics, Inc. produces and sells Tepezza. Tepez is an indication for Teprotumumab rbw, an infusion biochemical used in the treatment of Graves ostracy syndrome. The only drug in existence that treats these conditions.
Tepezza’s Pre-Approval Clinical Trials
Tepezza received FDA approval in a small amount of time. Phase 2 or phase three clinical studies included a total of just 171 patients, with an average of 87 receiving the placebo. This seems to be unsatisfactory data on drug marketing to millions. Horizon Therapeutics reported on Friday that more than half a dozen test subjects were hearing impaired when compared to other drugs and exhibited similar symptoms. Some of these hearing impairments were identified as sensorineural hearing loss, which is a serious and potentially irreversible condition.
What Is Thyroid Eye Disease (TED) or Graves Eye Disease?
Graves disease has a negative impact on glands in the lower neck that produce hormones that regulate body functions like weight, body temperature menstrual cycle, and growth and development. In thyroid conditions, the thyroid becomes over-active causing symptoms. Nearly half of people who have Graves Disease have ophthalmopathy. The symptoms can occur as swelling and irritation in the eyes. It’s common for ted patients to have an eye bulge.
Tepezza Study Discloses Potential Serious Side Effects in 65% of Patients
Tepezza may cause an eye problem and is commonly used as a treatment option in patients suffering from teprotumumumab. In addition to hearing issues, some patients have reported experiencing double vision as a symptom of Thyroid Eye Disease, which Tepezza aims to alleviate. Patients take Tepezza in regular doses to avoid eye bulging. In 2021 the Stanford School of Medicine conducted a small survey of Tepezza customers. It was found that 65% of the participants suffered severe ear-ringing problems as well as hearing loss. Some impairments appears permanent, but there is still more work needed to validate these results.
Scientific Studies And Published Case Reports Link Tepezza to Hearing Loss and Tinnitus
In teprotalumumab, several oral aortodontists wrote scientific papers. Numerous studies have shown teprotalumab may cause hearing loss. These studies have led to numerous Tepezza hearing loss claims, as affected individuals seek legal recourse for their auditory injuries. Below we list some of the published cases that show the effects on the health of patients with Tepezza hearing loss, tinnitus, or similar problems.
Is Hearing Loss From Tepezza Permanent?
The most severe hearing loss associated with Tepezza infusion therapy includes partial and permanent hearing damage.
Is Hearing Loss From Tepezza Reversible?
Not everyone suffering hearing loss due to TEPEZA infusion is easily reversed.
Does Tepezza Work?
No. Tepezza does not prevent thyroid eye disease. However, treatment with Tepezza can be used to reduce certain symptoms associated with the disease. Tepezza has been found to reduce symptoms of TED like bulging eyelids and double vision.
Tepezza Injuries
Several people with ear problems reported the effects in a study of the gastrointestinal tract. Many patients have suffered hearing loss, with some cases being so severe that they have suffered permanent hearing loss. During the course of the 3.6 injections, Tepezza had a pronounced hearing ailment. Several patients experienced a variety of symptoms. Tepezza may also be associated with sensitive hearing and deafness, according to therapeutic risk management.
Tepezza Hearing Impairment Litigation Updates
The Tepezza brand is being updated to add warnings for permanently deaf people, as the Tepezza hearing loss lawsuit progresses. The lawsuits allege that Tepezza infusions have led to severe and permanent hearing issues, prompting the need for updated warnings. That was an excellent fact in this case. June 2, 2023: Several Tepezza-related hearing impairment lawsuits have now been transferred to the Northern District of Illinois for re-tagging.
What Settlements Have Been Reached in Tepezza Lawsuits?
There’s currently no settlement for the Tepezza hearing loss lawsuit or Tinnitus cases. These Tepezza lawsuits claim that the manufacturer failed to adequately warn about the risks of hearing loss and tinnitus. In Illinois, a federal MDL arose in the case concerning The Tepezza. We represent lawyers on the Advisory Board of the MDL. MDLs are the first step in the legal system which initiates settlement negotiations. Once MDLs were created discovery of evidence and trial could commence which would lead to serious settlement discussions. We will seek damages from patients who receive treatment with teprotumumab to help them overcome tinnitus.
Potential Settlement Payouts for Tepezza Hearing Loss Lawsuits
It’s quite premature to estimate the potential value of a Tepezza hearing loss lawsuit against Tepezza. The severity of the injuries, including cases of permanent hearing loss, will significantly impact the potential Tepezza settlement amounts. There is currently too much variability for this to determine if this case is viable. The mass tort lawyers believe these lawsuits will eventually reach a huge Tepezza settlement. We have to provide a good estimate of the cost of settling the case if we are going to win a hearing loss case. Our legal experts estimate that a Tepezza hearing loss claim in favorable circumstances could have settled compensation between $450,000 and $450,000.
Understanding Tepezza and Its Uses
Tepezza, or teprotumumab, was hailed as a breakthrough treatment for thyroid eye disease when it was first introduced. This condition, often associated with Graves’ disease, causes inflammation and swelling in the muscles and tissues around the eyes, leading to discomfort and vision problems. Tepezza works by targeting and inhibiting a protein involved in this inflammation, providing relief to many patients.
TEPEZZA causes muscle aches and pains as well as diarrhea, headaches, hair loss, hair fall, and hair loss.
However, as its usage increased, so did reports of adverse side effects. Patients began to experience hearing-related issues, including hearing loss and tinnitus, which they attributed to their Tepezza treatments. Patients have reported a range of hearing problems, including hearing loss and tinnitus, which they believe are linked to their Tepezza treatments. These side effects were not initially prominent in clinical trials, raising questions about the drug’s safety profile and the thoroughness of its initial testing phases.
The growing number of adverse reports led to further investigations. Medical experts and researchers delved into the possible mechanisms by which Tepezza could affect the auditory system. Their findings suggested that the drug might impact certain proteins in the ear, leading to the observed hearing issues. This discovery prompted regulatory bodies to re-evaluate the drug’s safety and efficacy.
The Legal Landscape Surrounding Tepezza
As the reports of hearing loss and tinnitus became more widespread, affected patients began to seek legal recourse through a Tepezza hearing loss lawsuit. Many affected patients are now looking to file a Tepezza lawsuit to seek compensation for the hearing-related side effects they have endured. Mass tort litigation emerged as a significant avenue for these individuals to voice their grievances and seek compensation. Mass tort cases differ from class action lawsuits in that each plaintiff’s case is handled individually, though they are grouped together for efficiency and consistency.
Tepezza lawyers are actively representing these patients, focusing on the alleged failure to warn about the drug’s risks.
Legal experts have focused on several key areas in these cases. First, they are examining whether the manufacturer of Tepezza failed to adequately warn patients and healthcare providers about the potential risks. This includes scrutinizing the drug’s labeling, marketing materials, and any communication from the company regarding side effects. Additionally, there is a close look at the clinical trials and testing phases to determine if any adverse effects were overlooked or underreported.
The outcomes of these cases could have far-reaching implications. Successful litigation may lead to significant compensation for affected individuals and could also prompt changes in how the drug is prescribed and monitored. It might also influence future regulatory policies to ensure better protection for patients and more stringent requirements for drug approvals.
Impact on Patients and Healthcare Providers
The revelations about Tepezza’s potential side effects have had a profound impact on both patients and healthcare providers. For patients, the possibility of hearing loss or tinnitus adds a new layer of anxiety to their treatment regimen. Many individuals are now faced with the difficult decision of whether to continue their treatment, balancing the benefits of their thyroid eye disease against the risks to their auditory health. The ongoing Tepezza lawsuit has added to the anxiety, as patients weigh the benefits of the treatment against the potential legal and health risks.
Healthcare providers are also navigating this complex landscape. They must weigh the emerging data and patient reports against the clinical benefits of Tepezza. This often involves extensive consultations with patients, discussing the risks and benefits in detail, and exploring alternative treatments. The situation underscores the importance of vigilant post-market surveillance and open communication between healthcare providers and patients.
Additionally, healthcare providers are playing a crucial role in reporting and documenting adverse effects. Their observations and patient reports are vital for ongoing research and for informing regulatory bodies. This collaborative effort aims to ensure that patient safety remains a priority and that any potential risks are promptly addressed.
Why Choose Mass Tort America for Your Case?
Mass Tort America is committed to advocating for patients affected by Tepezza, including those involved in a Tepezza hearing loss lawsuit. Our experienced legal team understands the intricacies of mass tort litigation and the specific challenges posed by pharmaceutical cases. We strive to provide personalized attention to each client, ensuring that their unique circumstances are thoroughly considered and addressed. Our team of experienced Tepezza lawyers is well-versed in handling these complex cases and is dedicated to achieving the best outcomes for our clients.
By choosing Mass Tort America, you benefit from our extensive network and resources. Our Concierge Team is dedicated to coordinating all aspects of your case, from initial consultations to gathering medical records and expert testimonies. We aim to alleviate the burden on our clients, allowing them to focus on their health and well-being.
If you or a loved one has been affected by Tepezza, we encourage you to contact Mass Tort America. Our team is ready to help you seek the justice and compensation you deserve. Call us at 800-356-4338 or visit our contact form at https://masstortamerica.com/contact/.
